Leuprorelin acetate Prescribing at DR KHAN & PARTNERS
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
175
Total Quantity
180
NHS Cost
£33.7K
vs National Avg
+277.6%
DR KHAN & PARTNERS prescribed 175 items of Leuprorelin acetate over the last 12 months at a cost of £33,722 to the NHS. This is 277.6% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
17
Jul 2026
16
Jul 2026
12
Jul 2026
18
Jul 2026
18
Jul 2026
9
Jul 2026
17
Jul 2026
15
Jul 2026
16
Jul 2026
12
Jul 2026
14
Jul 2026
11
Prescribing Details
| Total Items | 175 |
|---|---|
| Total Quantity | 180 |
| Total NHS Cost | £33,722 |
| Presentations | 3 different forms |
| vs National Average | +277.6% |
Leuprorelin acetate Prescribing Comparison
| This practice | 175 items |
|---|---|
| National average per practice | 46 items |
| Difference | +277.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.